Literature DB >> 31183612

Resveratrol, an activator of SIRT1, improves ER stress by increasing clusterin expression in HepG2 cells.

Jinmi Lee1, Seok-Woo Hong1, Hyemi Kwon2, Se Eun Park2, Eun-Jung Rhee2, Cheol-Young Park2, Ki-Won Oh2, Sung-Woo Park2, Won-Young Lee3.   

Abstract

Endoplasmic reticulum stress (ER stress) is involved in lipid metabolism and lipotoxicity and can lead to apoptosis. Resveratrol, a sirtuin 1 (SIRT1) agonist, prevents ER stress and improves ER stress-induced hepatic steatosis and cell death. Clusterin is a secreted chaperone and has roles in various physiological processes. However, changes in the expression of clusterin upon ER stress and the connection between SIRT1 and clusterin in protection against ER stress are not well known. In cells treated with tunicamycin, resveratrol increased the expression of clusterin mRNA and protein and the secreted clusterin protein level in conditioned medium. Resveratrol decreased protein expression of the ER stress markers, p-PERK, p-IRE1α, and CHOP, and increased the expression of the ER-associated degradation (ERAD) factors, SEL1L and HRD1, in tunicamycin-treated cells. However, no changes in the expression of these genes were observed in clusterin siRNA-transfected cells. Moreover, increased LAMP2 and LC3 expression and decreased Rubicon expression were observed in cells treated with resveratrol or secreted clusterin. These data suggest that SIRT1 activation by resveratrol attenuates ER stress by promoting protective processes such as ERAD and autophagy pathways and that these protective effects are mediated by clusterin.

Entities:  

Keywords:  Autophagy; Chaperone; Clusterin; ER stress; ERAD; SIRT1

Mesh:

Substances:

Year:  2019        PMID: 31183612      PMCID: PMC6629741          DOI: 10.1007/s12192-019-01012-z

Source DB:  PubMed          Journal:  Cell Stress Chaperones        ISSN: 1355-8145            Impact factor:   3.667


  40 in total

Review 1.  Molecular chaperones in targeting misfolded proteins for ubiquitin-dependent degradation.

Authors:  Franziska Kriegenburg; Lars Ellgaard; Rasmus Hartmann-Petersen
Journal:  FEBS J       Date:  2012-01-04       Impact factor: 5.542

2.  Clusterin is an extracellular chaperone that specifically interacts with slowly aggregating proteins on their off-folding pathway.

Authors:  Stephen Poon; Teresa M Treweek; Mark R Wilson; Simon B Easterbrook-Smith; John A Carver
Journal:  FEBS Lett       Date:  2002-02-27       Impact factor: 4.124

Review 3.  Role of endoplasmic reticulum stress in metabolic disease and other disorders.

Authors:  Lale Ozcan; Ira Tabas
Journal:  Annu Rev Med       Date:  2012       Impact factor: 13.739

4.  The chaperone activity of clusterin is dependent on glycosylation and redox environment.

Authors:  Philipp Rohne; Hans Prochnow; Steven Wolf; Benjamin Renner; Claudia Koch-Brandt
Journal:  Cell Physiol Biochem       Date:  2014-11-03

5.  Delayed activation of insulin-like growth factor-1 receptor/Src/MAPK/Egr-1 signaling regulates clusterin expression, a pro-survival factor.

Authors:  Tracy Criswell; Meghan Beman; Shinako Araki; Konstantin Leskov; Eva Cataldo; Lindsey D Mayo; David A Boothman
Journal:  J Biol Chem       Date:  2005-02-02       Impact factor: 5.157

Review 6.  Unfolded protein response signaling and metabolic diseases.

Authors:  Jaemin Lee; Umut Ozcan
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

7.  Modulation of different clusterin isoforms in human colon tumorigenesis.

Authors:  Sabina Pucci; Elena Bonanno; Flavia Pichiorri; Caterina Angeloni; Luigi Giusto Spagnoli
Journal:  Oncogene       Date:  2004-03-25       Impact factor: 9.867

Review 8.  The role of ER stress in lipid metabolism and lipotoxicity.

Authors:  Jaeseok Han; Randal J Kaufman
Journal:  J Lipid Res       Date:  2016-05-04       Impact factor: 5.922

9.  Heat shock protein 72 modulates pathways of stress-induced apoptosis.

Authors:  K A Buzzard; A J Giaccia; M Killender; R L Anderson
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

10.  Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice.

Authors:  Satoshi Tanaka; Hayato Hikita; Tomohide Tatsumi; Ryotaro Sakamori; Yasutoshi Nozaki; Sadatsugu Sakane; Yuto Shiode; Tasuku Nakabori; Yoshinobu Saito; Naoki Hiramatsu; Keisuke Tabata; Tsuyoshi Kawabata; Maho Hamasaki; Hidetoshi Eguchi; Hiroaki Nagano; Tamotsu Yoshimori; Tetsuo Takehara
Journal:  Hepatology       Date:  2016-10-21       Impact factor: 17.298

View more
  6 in total

1.  Resveratrol Alleviates the Inhibitory Effect of Tunicamycin-Induced Endoplasmic Reticulum Stress on Expression of Genes Involved in Thyroid Hormone Synthesis in FRTL-5 Thyrocytes.

Authors:  Gaiping Wen; Klaus Eder; Robert Ringseis
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

2.  Resveratrol Reduces COMPopathy in Mice Through Activation of Autophagy.

Authors:  Jacqueline T Hecht; Francoise Coustry; Alka C Veerisetty; Mohammad G Hossain; Karen L Posey
Journal:  JBMR Plus       Date:  2021-01-22

3.  Resveratrol promotes osteoblastic differentiation in a rat model of postmenopausal osteoporosis by regulating autophagy.

Authors:  Wei Wang; Li-Mei Zhang; Chang Guo; Jian-Feng Han
Journal:  Nutr Metab (Lond)       Date:  2020-04-16       Impact factor: 4.169

4.  Impact of Chaperone-Mediated Autophagy in Brain Aging: Neurodegenerative Diseases and Glioblastoma.

Authors:  Jaione Auzmendi-Iriarte; Ander Matheu
Journal:  Front Aging Neurosci       Date:  2021-01-28       Impact factor: 5.750

5.  SIRT1 Is Involved in the Neuroprotection of Pterostilbene Against Amyloid β 25-35-Induced Cognitive Deficits in Mice.

Authors:  Lin Zhu; Fangjin Lu; Xiaoran Zhang; Siyuan Liu; Ping Mu
Journal:  Front Pharmacol       Date:  2022-04-14       Impact factor: 5.988

Review 6.  Resveratrol and Markers of Polycystic Ovary Syndrome: a Systematic Review of Animal and Clinical Studies.

Authors:  Sara Shojaei-Zarghani; Maryam Rafraf
Journal:  Reprod Sci       Date:  2021-07-26       Impact factor: 2.924

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.